Flares of systemic lupus erythematosus during pregnancy and the puerperium: Prevention, diagnosis and management

Expert Review of Clinical Immunology

Volumn 8, Issue 5, 2012, Pages 439-453

  Stojan, George ^a   Baer, Alan N ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

disease activity; lupus; preeclampsia; pregnancy; systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; BELIMUMAB; BETAMETHASONE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEXAMETHASONE; GLUCOCORTICOID; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PREDNISONE; RITUXIMAB; TACROLIMUS;

BONE NECROSIS; BRAIN HEMORRHAGE; CLEFT LIP; CLEFT PALATE; CONGENITAL MALFORMATION; DIGESTIVE SYSTEM PERFORATION; DISEASE ACTIVITY; DISEASE EXACERBATION; FETUS MALFORMATION; FETUS WASTAGE; GASTROINTESTINAL HEMORRHAGE; GROWTH RETARDATION; HEMATOPOIESIS; HUMAN; HYPERTENSION; INFECTION; INTRAUTERINE GROWTH RETARDATION; LABOR; LOW DRUG DOSE; LUPUS ERYTHEMATOSUS NEPHRITIS; MICROANGIOPATHY; NECROTIZING ENTEROCOLITIS; NEPHROTOXICITY; NEWBORN INFECTION; OLIGOHYDRAMNIOS; OSTEOPENIA; PATENT DUCTUS ARTERIOSUS; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURE LABOR; PULMONARY HYPERTENSION; REMISSION; REVIEW; RISK FACTOR; SIDE EFFECT; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA;

FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

EID: 84865003007     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/eci.12.36     Document Type: Review

References (116)

1. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40(9), 1725 (1997
2. Clark CA, Spitzer KA, Laskin CA. Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period. J. Rheumatol. 32(9), 1709-1712 (2005
3. Chakravarty EF, Nelson L, Krishnan E. Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 54(3), 899-907 (2006
4. Clowse ME, Jamison M, Myers E, James AH. A national study of the complications of lupus in pregnancy. Am. J. Obstet. Gynecol. 199(2), 127.e1-e6 (2008
5. Chakravarty EF, Colón I, Langen ES et al. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am. J. Obstet. Gynecol. 192(6), 1897-1904 (2005
6. Moroni G, Ponticelli C. The risk of pregnancy in patients with lupus nephritis. J. Nephrol. 16(2), 161-167 (2003
7. Smyth A, Oliveira GH, Lahr BD, Bailey KR, Norby SM, Garovic VD. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin. J. Am. Soc. Nephrol. 5(11), 2060-2068 (2010
8. Buyon JP, Garabet L, Kim M et al. Favorable prognosis in a large, prospective multicenter study of lupus pregnancies. Arthritis Rheum. 63(10), S669 (2011
9. Clowse ME, Magder LS, Witter F, Petri M. Early risk factors for pregnancy loss in lupus. Obstet. Gynecol. 107(2 Pt 1), 293-299 (2006
10. Huong DL, Wechsler B, Vauthier-Brouzes D, Beaufils H, Lefebvre G, Piette JC. Pregnancy in past or present lupus nephritis: A study of 32 pregnancies from a single centre. Ann. Rheum. Dis. 60(6), 599-604 (2001
11. Julkunen H, Kaaja R, Palosuo T, Grönhagen-Riska C, Teramo K. Pregnancy in lupus nephropathy. Acta Obstet. Gynecol. Scand. 72(4), 258-263 (1993
12. Cortés-Hernández J, Ordi-Ros J, Paredes F, Casellas M, Castillo F, Vilardell-Tarres M. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: A prospective study of 103 pregnancies. Rheumatology (Oxford) 41(6), 643-650 (2002
13. Imbasciati E, Tincani A, Gregorini G et al. Pregnancy in women with pre-existing lupus nephritis: Predictors of fetal and maternal outcome. Nephrol. Dial. Transplant. 24(2), 519-525 (2009
14. Wagner SJ, Craici I, Reed D et al. Maternal and foetal outcomes in pregnant patients with active lupus nephritis. Lupus 18(4), 342-347 (2009
15. Germain S, Nelson-Piercy C. Lupus nephritis and renal disease in pregnancy. Lupus 15(3), 148-155 (2006
16. Hayslett JP. The effect of systemic lupus erythematosus on pregnancy and pregnancy outcome. Am. J. Reprod. Immunol. 28(3-4), 199-204 (1992
17. Yasmeen S, Wilkins EE, Field NT, Sheikh RA, Gilbert WM. Pregnancy outcomes in women with systemic lupus erythematosus. J. Matern. Fetal. Med. 10(2), 91-96 (2001
18. Petri M. The Hopkins Lupus Pregnancy Center: Ten key issues in management. Rheum. Dis. Clin. North Am. 33(2), 227-35, v (2007
19. Ruiz-Irastorza G, Khamashta MA. Lupus and pregnancy: Ten questions and some answers. Lupus 17(5), 416-420 (2008
20. COG Committee on Practice Bulletins- Obstetrics. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Obstet. Gynecol. 99(1), 159-167 (2002
21. Clowse ME, Magder L, Witter F, Petri M. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum. 54(11), 3640-3647 (2006
22. Moroni G, Quaglini S, Banfi G et al. Pregnancy in lupus nephritis. Am. J. Kidney Dis. 40(4), 713-720 (2002
23. Arngrímsson R, Sigurõardóttir S, Frigge ML et al. A genome-wide scan reveals a maternal susceptibility locus for preeclampsia on chromosome 2p13. Hum. Mol. Genet. 8(9), 1799-1805 (1999
24. Moses EK, Lade JA, Guo G et al. A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for preeclampsia, on chromosome 2. Am. J. Hum. Genet. 67(6), 1581-1585 (2000
25. GOPEC Consortium. Disentangling fetal and maternal susceptibility for preeclampsia: A British multicenter candidategene study. Am. J. Hum. Genet. 77(1), 127-131 (2005
26. Mouzat K, Mercier E, Polge A et al. A common polymorphism in NR1H2 (LXRbeta) is associated with preeclampsia. BMC Med. Genet. 12, 145 (2011
27. Salmon JE, Heuser C, Triebwasser M et al. Mutations in complement regulatory proteins predispose to preeclampsia: A genetic analysis of the PROMISSE cohort. PLoS Med. 8(3), e1001013 (2011
28. Mintz G, Niz J, Gutierrez G, Garcia-Alonso A, Karchmer S. Prospective study of pregnancy in systemic lupus erythematosus. Results of a multidisciplinary approach. J. Rheumatol. 13(4), 732-739 (1986
29. Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum. 34(12), 1538-1545 (1991
30. Tincani A, Bompane D, Danieli E, Doria A. Pregnancy, lupus and antiphospholipid syndrome (Hughes syndrome). Lupus 15(3), 156-160 (2006
31. Molad Y, Borkowski T, Monselise A et al. Maternal and fetal outcome of lupus pregnancy: A prospective study of 29 pregnancies. Lupus 14(2), 145-151 (2005
32. Doria A, Tincani A, Lockshin M. Challenges of lupus pregnancies. Rheumatology (Oxford) 47(Suppl. 3), iii9-ii12 (2008
33. Lockshin MD, Reinitz E, Druzin ML, Murrman M, Estes D. Lupus pregnancy. Case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy. Am. J. Med. 77(5), 893-898 (1984
34. Urowitz MB, Gladman DD, Farewell VT, Stewart J, McDonald J. Lupus and pregnancy studies. Arthritis Rheum. 36(10), 1392-1397 (1993
35. Tandon A, Ibañez D, Gladman DD, Urowitz MB. The effect of pregnancy on lupus nephritis. Arthritis Rheum. 50(12), 3941-3946 (2004
36. Wong KL, Chan FY, Lee CP. Outcome of pregnancy in patients with systemic lupus erythematosus. A prospective study. Arch. Intern. Med. 151(2), 269-273 (1991
37. Ruiz-Irastorza G, Lima F, Alves J et al. Increased rate of lupus flare during pregnancy and the puerperium: A prospective study of 78 pregnancies. Br. J. Rheumatol. 35(2), 133-138 (1996
38. Clowse ME, Magder LS, Witter F, Petri M. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum. 52(2), 514-521 (2005
39. Doria A, Ghirardello A, Iaccarino L et al. Pregnancy, cytokines, and disease activity in systemic lupus erythematosus. Arthritis Rheum. 51(6), 989-995 (2004
40. Petri M. Hopkins Lupus Pregnancy Center: 1987 to 1996. Rheum. Dis. Clin. North Am. 23(1), 1-13 (1997
41. Doria A, Cutolo M, Ghirardello A et al. Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus. Arthritis Rheum. 47(2), 202-209 (2002
42. Smith-Bouvier DL, Divekar AA, Sasidhar M et al. A role for sex chromosome complement in the female bias in autoimmune disease. J. Exp. Med. 205(5), 1099-1108 (2008
43. Tower C, Crocker I, Chirico D, Baker P, Bruce I. SLE and pregnancy: The potential role for regulatory T cells. Nat. Rev. Rheumatol. 7(2), 124-128 (2011
44. Lee HY, Hong YK, Yun HJ, Kim YM, Kim JR, Yoo WH. Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus. Rheumatology (Oxford) 47(6), 789-794 (2008
45. Bonelli M, Savitskaya A, von Dalwigk K et al. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE). Int. Immunol. 20(7), 861-868 (2008
46. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol. 5(3), 266-271 (2004
47. Tilburgs T, Roelen DL, van der Mast BJ et al. Differential distribution of CD4+ CD25(bright) and CD8+CD28- T-cells in decidua and maternal blood during human pregnancy. Placenta 27(Suppl. A), S47-S53 (2006
48. Sasaki Y, Sakai M, Miyazaki S, Higuma S, Shiozaki A, Saito S. Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol. Hum. Reprod. 10(5), 347-353 (2004
49. Wang B, Gladman DD, Urowitz MB. Fatigue in lupus is not correlated with disease activity. J. Rheumatol. 25(5), 892-895 (1998
50. Tench CM, McCurdie I, White PD, D'Cruz DP. The prevalence and associations of fatigue in systemic lupus erythematosus. Rheumatology (Oxford) 39(11), 1249-1254 (2000
51. Geraghty LN, Pomeranz MK. Physiologic changes and dermatoses of pregnancy. Int. J. Dermatol. 50(7), 771-782 (2011
52. Ostensen M, Rugelsjoen A, Wigers SH. The effect of reproductive events and alterations of sex hormone levels on the symptoms of fibromyalgia. Scand. J. Rheumatol. 26(5), 355-360 (1997
53. Bayliss DA, Millhorn DE. Central neural mechanisms of progesterone action: Application to the respiratory system. J. Appl. Physiol. 73(2), 393-404 (1992
54. Peck TM, Arias F. Hematologic changes associated with pregnancy. Clin. Obstet. Gynecol. 22(4), 785-798 (1979
55. Burrows RF, Kelton JG. Incidentally detected thrombocytopenia in healthy mothers and their infants. N. Engl. J. Med. 319(3), 142-145 (1988
56. Buyon JP, Cronstein BN, Morris M, Tanner M, Weissmann G. Serum complement values (C3 and C4) to differentiate between systemic lupus activity and pre-eclampsia. Am. J. Med. 81(2), 194-200 (1986
57. Buyon JP, Kalunian KC, Ramsey-Goldman R et al. Assessing disease activity in SLE patients during pregnancy. Lupus 8(8), 677-684 (1999
58. Clowse ME, Magder LS, Petri M. The clinical utility of measuring complement and anti-dsDNA antibodies during pregnancy in patients with systemic lupus erythematosus. J. Rheumatol. 38(6), 1012-1016 (2011
59. Carlin A, Alfirevic Z. Physiological changes of pregnancy and monitoring. Best Pract. Res. Clin. Obstet. Gynaecol. 22(5), 801-823 (2008
60. Branch DW. Physiologic adaptations of pregnancy. Am. J. Reprod. Immunol. 28(3-4), 120-122 (1992
61. Ruiz-Irastorza G, Khamashta MA, Gordon C et al. Measuring systemic lupus erythematosus activity during pregnancy: Validation of the lupus activity index in pregnancy scale. Arthritis Rheum. 51(1), 78-82 (2004
62. Levy RA, Vilela VS, Cataldo MJ et al. Hydroxychloroquine (HCQ) in lupus pregnancy: Double-blind and placebocontrolled study. Lupus 10(6), 401-404 (2001
63. Chen HH, Lin HC, Yeh JC, Chen CP. Renal biopsy in pregnancies complicated by undetermined renal disease. Acta Obstet. Gynecol. Scand. 80(10), 888-893 (2001
64. Benifla JL, Tchobroutsky C, Uzan M, Sultan Y, Weill BJ, Laumond-Barny S. Predictive value of uterine artery velocity waveforms in pregnancies complicated by systemic lupus erythematosus and the antiphospholipid syndrome. Fetal. Diagn. Ther. 7(3-4), 195-202 (1992
65. Le Thi Huong D, Wechsler B, Vauthier-Brouzes D et al. The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome. Rheumatology (Oxford) 45(3), 332-338 (2006
66. Guzman E, Schulman H, Bracero L, Rochelson B, Farmakides G, Coury A. Uterine-umbilical artery Doppler velocimetry in pregnant women with systemic lupus erythematosus. J. Ultrasound Med. 11(6), 275-281 (1992
67. Smith GC, Yu CK, Papageorghiou AT, Cacho AM, Nicolaides KH, Fetal Medicine Foundation Second Trimester Screening Group. Maternal uterine artery Doppler flow velocimetry and the risk of stillbirth. Obstet. Gynecol. 109(1), 144-151 (2007
68. Gilpin BJ, Loechel F, Mattei MG, Engvall E, Albrechtsen R, Wewer UM. A novel, secreted form of human ADAM 12 (meltrin alpha) provokes myogenesis in vivo. J. Biol. Chem. 273(1), 157-166 (1998
69. Cole LA. Biological functions of hCG and hCG-related molecules. Reprod. Biol. Endocrinol. 8, 102 (2010
70. Birdsall M, Ledger W, Groome N, Abdalla H, Muttukrishna S. Inhibin A and activin A in the first trimester of human pregnancy. J. Clin. Endocrinol. Metab. 82(5), 1557-1560 (1997
71. Burger O, Pick E, Zwickel J et al. Placental protein 13 (PP-13): Effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies. Placenta 25(7), 608-622 (2004
72. Levine RJ, Maynard SE, Qian C et al. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 350(7), 672-683 (2004
73. Guibourdenche J, Frendo JL, Pidoux G et al. Expression of pregnancy-associated plasma protein-A (PAPP-A) during human villous trophoblast differentiation in vitro. Placenta 24(5), 532-539 (2003
74. Kuc S, Wortelboer EJ, van Rijn BB, Franx A, Visser GH, Schielen PC. Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: A systematic review. Obstet. Gynecol. Surv. 66(4), 225-239 (2011
75. Audibert F, Boucoiran I, An N et al. Screening for preeclampsia using firsttrimester serum markers and uterine artery Doppler in nulliparous women. Am. J. Obstet. Gynecol. 203(4), 383.e1-e8 (2010
76. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am. J. Obstet. Gynecol. 169(4), 1000-1006 (1993
77. Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: Clinical issues and management. A review. BMC Pregnancy Childbirth 9, 8 (2009
78. Joshi D, James A, Quaglia A, Westbrook RH, Heneghan MA. Liver disease in pregnancy. Lancet 375(9714), 594-605 (2010
79. Vesely SK, George JN, Lámmle B et al. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 102(1), 60-68 (2003
80. George JN. Evaluation and management of patients with thrombotic thrombocytopenic purpura. J. Intensive Care Med. 22(2), 82-91 (2007
81. Mori Y, Wada H, Gabazza EC et al. Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity. Transfusion 42(5), 572-580 (2002
82. Hamasaki K, Mimura T, Kanda H et al. Systemic lupus erythematosus and thrombotic thrombocytopenic purpura: A case report and literature review. Clin. Rheumatol. 22(4-5), 355-358 (2003
83. Matsuyama T, Kuwana M, Matsumoto M, Isonishi A, Inokuma S, Fujimura Y. Heterogeneous pathogenic processes of thrombotic microangiopathies in patients with connective tissue diseases. Thromb. Haemost. 102(2), 371-378 (2009
84. Gómez-Puerta JA, Cervera R, Espinosa G et al. Catastrophic antiphospholipid syndrome during pregnancy and puerperium: Maternal and fetal characteristics of 15 cases. Ann. Rheum. Dis. 66(6), 740-746 (2007
85. Pauzner R, Dulitzky M, Carp H et al. Hepatic infarctions during pregnancy are associated with the antiphospholipid syndrome and in addition with complete or incomplete HELLP syndrome. J. Thromb. Haemost. 1(8), 1758-1763 (2003
86. østensen M, Khamashta M, Lockshin M et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res. Ther. 8(3), 209 (2006
87. Izmirly PM, Kim MY, Llanos C et al. Evaluation of the risk of anti-SSA/Ro-SSB/ La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine. Ann. Rheum. Dis. 69(10), 1827-1830 (2010
88. Lockshin MD, Sammaritano LR. Lupus pregnancy. Autoimmunity 36(1), 33-40 (2003
89. Friedman DM, Kim MY, Copel JA et al. PRIDE Investigators. Utility of cardiac monitoring in fetuses at risk for congenital heart block: The PR Interval and Dexamethasone Evaluation (PRIDE) prospective study. Circulation 117(4), 485-493 (2008
90. Petri M. Pregnancy in SLE. Baillieres Clin. Rheumatol. 12(3), 449-476 (1998
91. Pradat P, Robert-Gnansia E, Di Tanna GL, et al. Contributors to the MADRE database. First trimester exposure to corticosteroids and oral clefts. Birth Defects Res. Part A Clin. Mol. Teratol. 67(12), 968-970 (2003
92. Canfield MA, Honein MA, Yuskiv N et al. National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001. Birth Defects Res. Part A Clin. Mol. Teratol. 76(11), 747-756 (2006
93. Clowse MEB, Magder LS, Witter F, Petri M. Azathioprine use in lupus pregnancy. Arthritis Rheum. 52(9 Suppl.), S386-S387 (2005
94. Mintz G, Gutiérrez G, Delezé M, Rodríguez E. Systemic lupus erythematosus in pregnancy. Ann. Intern. Med. 94(5), 667-677 (1981
95. Szeto CC, Kwan BC, Lai FM et al. Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis. Rheumatology (Oxford) 47(11), 1678-1681 (2008
96. Alsuwaida A. Successful management of systemic lupus erythematosus nephritis flare-up during pregnancy with tacrolimus. Mod. Rheumatol. 21(1), 73-75 (2011
97. Bar J, Stahl B, Hod M, Wittenberg C, Pardo J, Merlob P. Is immunosuppression therapy in renal allograft recipients teratogenic? A single-center experience. Am. J. Med. Genet. A 116A(1), 31-36 (2003
98. Clowse ME, Magder L, Petri M. Cyclophosphamide for lupus during pregnancy. Lupus 14(8), 593-597 (2005
99. Kart Köseoglu H, Yücel AE, Künefeci G, Ozdemir FN, Duran H. Cyclophosphamide therapy in a serious case of lupus nephritis during pregnancy. Lupus 10(11), 818-820 (2001
100. Ostensen M, Förger F. Treatment with biologics of pregnant patients with rheumatic diseases. Curr. Opin. Rheumatol. 23(3), 293-298 (2011
101. Pham T, Fautrel B, Gottenberg JE et al. Rheumatic Diseases & Inflammation Group (Club Rhumatismes et Inflammation, CRI) of the French Society for Rheumatology (Société Francaise de Rhumatologie, SFR). Rituximab (MabThera) therapy and safety management. Clinical tool guide. Joint Bone Spine 75(Suppl. 1), S1-S99 (2008
102. Chakravarty EF, Murray ER, Kelman A, Farmer P. Pregnancy outcomes after maternal exposure to rituximab. Blood 117(5), 1499-1506 (2011
103. Sibai BM. Imitators of severe pre-eclampsia. Semin. Perinatol. 33(3), 196-205 (2009
104. Martin JN Jr, Bailey AP, Rehberg JF, Owens MT, Keiser SD, May WL. Thrombotic thrombocytopenic purpura in 166 pregnancies: 1955-2006. Am. J. Obstet. Gynecol. 199(2), 98-104 (2008
105. Lê Huong D, Wechsler B, Vauthier-Brouzes D et al. Outcome of planned pregnancies in systemic lupus erythematosus: A prospective study on 62 pregnancies. Br. J. Rheumatol. 36(7), 772-777 (1997
106. Lima F, Buchanan NM, Khamashta MA, Kerslake S, Hughes GR. Obstetric outcome in systemic lupus erythematosus. Semin. Arthritis Rheum. 25(3), 184-192 (1995
107. Georgiou PE, Politi EN, Katsimbri P, Sakka V, Drosos AA. Outcome of lupus pregnancy: A controlled study. Rheumatology (Oxford) 39(9), 1014-1019 (2000
108. Liu J, Zhao Y, Song Y et al. Pregnancy in women with systemic lupus erythematosus: A retrospective study of 111 pregnancies in Chinese women. J. Matern. Fetal. Neonatal. Med. 25(3), 261-266 (2012
109. Gladman DD, Tandon A, Ibañez D, Urowitz MB. The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications. J. Rheumatol. 37(4), 754-758 (2010
110. Al Arfaj AS, Khalil N. Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia. Lupus 19(14), 1665-1673 (2010
111. Ko HS, Ahn HY, Jang DG et al. Pregnancy outcomes and appropriate timing of pregnancy in 183 pregnancies in Korean patients with SLE. Int. J. Med. Sci. 8(7), 577-583 (2011
112. van den Broe NR, Letsky EA. Pregnancy and the erythrocyte sedimentation rate. BJOG 108(11), 1164-1167 (2001
113. Maternal Health and Safe Motherhood Programme. Prevention and Management of Severe Anaemia in Pregnancy: Report of a Technical Working Group, Geneva, 20-22 May 1991. WHO, Division of Family Health, Geneva, Switzerland (1993
114. Baer AN, Witter FR, Petri M. Lupus and pregnancy. Obstet Gynecol Surv. 66(10), 639-653 (2011
115. George JN. How I treat patients with thrombotic thrombocytopenic purpura: 2010. Blood 116(20), 4060-4069 (2010
116. Asherson RA, Cervera R, Piette JC et al. Catastrophic antiphospholipid syndrome: Clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 80(6), 355-377 (2001